US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.21

-0.0150-1.23%

Volume:10.25K

Turnover:12.46K

Market Cap:60.03M

PE:-1.08

High:1.29

Open:1.29

Low:1.19

Close:1.22

Loading ...

Overview Company News Filings

Press Release: Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

Sector Update: Health Care Stocks Slide in Afternoon Trading

MT Newswires Live

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger

MT Newswires Live

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences

Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3

MT Newswires Live

Hold Rating on Quanterix-Akoya Merger Amid Uncertainties and Potential Synergies

Akoya Biosciences downgraded to Neutral from Overweight at Piper Sandler

U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International

Akoya Biosciences Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $2.4 From $3

THOMSON REUTERS

Quanterix Announces Acquisition of Akoya Biosciences

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Akoya Biosciences Inc expected to post a loss of 16 cents a share - Earnings Preview

Kent Lake: to Nominate Directors to Quanterix Board in 2025 Annual Meeting

THOMSON REUTERS

Kent Lake Pr Llc: Believes Merger Agreement With Akoya Biosciences Significantly Undervalues Quanterix

THOMSON REUTERS

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences

Akoya Biosciences unveils strategic product roadmap

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

THOMSON REUTERS

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

Akoya Biosciences selects Argonaut Manufacturing as IVD manufacturing partner

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AKYA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AKYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKYA\",,,,,undefined,":{"symbol":"AKYA","market":"US","secType":"STK","nameCN":"Akoya Biosciences, Inc.","latestPrice":1.205,"timestamp":1746459486441,"preClose":1.22,"halted":0,"volume":10252,"delay":0,"floatShares":12504169,"shares":49816357,"eps":-1.120328,"marketStatus":"Trading","change":-0.015,"latestTime":"05-05 11:40:26 EDT","open":1.2902,"high":1.2902,"low":1.19,"amount":12458.530783600001,"amplitude":0.082131,"askPrice":1.21,"askSize":196,"bidPrice":1.2,"bidSize":240,"shortable":3,"etf":0,"ttmEps":-1.120328,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746475200000},"marketStatusCode":2,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":1.22,"postHourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.22,"latestTime":"16:05 EDT","volume":1037,"amount":1265.14,"timestamp":1746216305986},"volumeRatio":0.184097,"impliedVol":1.2541,"impliedVolPercentile":0.456},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKYA\",,,,,undefined,":{"symbol":"AKYA","floatShares":12504169,"roa":"-16.86%","roe":"-180.44%","lyrEps":-1.120328,"volumeRatio":0.184097,"shares":49816357,"dividePrice":0,"high":1.2902,"amplitude":0.082131,"preClose":1.22,"low":1.19,"week52Low":1.01,"pbRate":"7.90","psRate":"0.73","week52High":4.65,"institutionHeld":0,"latestPrice":1.205,"committee":0.100917,"eps":-1.120328,"divideRate":0,"volume":10252,"delay":0,"ttmEps":-1.120328,"open":1.2902,"prevYearClose":2.29,"prevWeekClose":1.22,"prevMonthClose":1.2,"prevQuarterClose":1.39,"fiveDayClose":1.31,"twentyDayClose":1.17,"sixtyDayClose":2.51},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AKYA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520500576","title":"Press Release: Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2520500576","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520500576?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:00","pubTimestamp":1742241600,"startTime":"0","endTime":"0","summary":"Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call. Believes Proposed Transaction with Akoya Significantly Undervalues Quanterix. Encourages Shareholders to Vote Against Transaction to Protect Long-Term Value of their Investment. Kent Lake PR LLC  is a holder of 7.47% of the outstanding common stock of Quanterix Corporation  . Kent Lake has previously issued a public presentation detailing its opposition to the Company's proposed transaction  with Akoya Biosciences  , and has also nominated three highly qualified, independent candidates for election to the Company's Board of Directors .Kent Lake urges Quanterix management to address the following questions related to the Transaction on its earnings call today:. enterprise value to Akoya shareholders and less than 18% to Quanterix. -- Akoya Going Concern: When evaluating Akoya's liquidity and going concern. which awards Akoya shareholders a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QTRX","AKYA"],"gpt_icon":0},{"id":"2518720743","title":"Sector Update: Health Care Stocks Slide in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720743","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518720743?lang=en_us&edition=fundamental","pubTime":"2025-03-12 02:01","pubTimestamp":1741716092,"startTime":"0","endTime":"0","summary":"Health care stocks were lower Tuesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each falling about 1.5%.The iShares Biotechnology ETF (IBB) dropped 2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GH","BK4568","LU0321505439.SGD","SG9999001176.USD","IE00BBT3K403.USD","LU0289739699.SGD","BK4592","IE00B19Z3581.USD","LU1894683264.USD","BK7095","BK4550","LU0321505868.SGD","QTRX","BK4533","BK4588","LU0225771236.USD","ARVN","SG9999013999.USD","BK4539","SG9999002224.SGD","LU0456855351.SGD","LU1066053197.SGD","LU0306806265.USD","SG9999003800.SGD","BK4581","LU1894683348.USD","LU1883839398.USD","IE00BLSP4452.SGD","SG9999011175.SGD","BK4196","BK4585","SGXZ57979304.SGD","XLV","BK4535","BK4007","LU0225284248.USD","AKYA","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","LU0868494617.USD","LU1057294990.SGD","LU1023059063.AUD","LU0234572021.USD","BK4534","LU0985481810.HKD","PFE.AU","IE000M9KFDE8.USD","IBB"],"gpt_icon":1},{"id":"2518728896","title":"Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728896","media":"MT Newswires Live","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518728896?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:39","pubTimestamp":1741703964,"startTime":"0","endTime":"0","summary":"Quanterix  shareholder Kent Lake said Tuesday that it opposes the company's proposed deal with Akoya Biosciences .Kent Lake, which owns 7.25% of Quanterix's stock, argued the deal is bad for Quanterix shareholders as it values Akoya almost five times higher than Quanterix, despite Quanterix's \"superior\" growth and market opportunity.Kent Lake said in its claims that Quanterix ended up bidding against itself for Akoya, as other potential buyers backed out. It also raised concerns about the Quanterix board, suggesting that some directors have conflicts of interest and have not acted in the best interests of shareholders.Kent Lake urged Quanterix stockholders to vote against the proposed merger and also said it recently nominated three independent board candidates to represent shareholders' interests better.Quanterix and Akoya Biosciences did not immediately reply to MT Newswires' request for comments.QTRX shares were up 3.5% and AKYA shares were 5.2% higher in recent trading.Price: 7.53,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","AKYA","QTRX","BK4121"],"gpt_icon":0},{"id":"2518743089","title":"Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2518743089","media":"Business Wire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518743089?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:00","pubTimestamp":1741694400,"startTime":"0","endTime":"0","summary":"Highlights that Quanterix’s Board is Essentially Rescuing Akoya at the Direct Expense of Quanterix Shareholders. Transaction Would Introduce Unnecessary Risk and Divert Cash and Management Focus Away from Quanterix’s Alzheimer’s Diagnostics Program, a Core Growth Opportunity. Calls on Quanterix Board to Answer Pressing Questions around Valuation, Process and Governance Issues in Connection with Transaction. Urges Shareholders to Vote Against Merger with Akoya to Protect the Future Value of Their Investment. RINCON, Puerto Rico, March 11, 2025----Kent Lake PR LLC  a holder of 7.25% of the outstanding common stock of Quanterix Corporation  , today issued a presentation to Quanterix shareholders in connection to Kent Lake’s opposition to the Company’s proposed transaction  with Akoya Biosciences  .The Transaction is a bad deal for Quanterix shareholders – The Transaction inexplicably values Akoya nearly 5x higher than Quanterix, despite Quanterix’s superior mix, growth and market opportun","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kent-lake-issues-investor-presentation-120000653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QTRX","BK4121","AKYA","BK4539"],"gpt_icon":0},{"id":"2517484919","title":"Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484919","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484919?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:02","pubTimestamp":1741179738,"startTime":"0","endTime":"0","summary":"Akoya Biosciences (AKYA) has an average rating of Hold and mean price target of $3.48, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKYA"],"gpt_icon":0},{"id":"2517499421","title":"Hold Rating on Quanterix-Akoya Merger Amid Uncertainties and Potential Synergies","url":"https://stock-news.laohu8.com/highlight/detail?id=2517499421","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517499421?lang=en_us&edition=fundamental","pubTime":"2025-03-05 18:07","pubTimestamp":1741169224,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst David Westenberg downgraded the rating on Akoya Biosciences (AKYA – Research Report) to a Hold yesterday, setting a price tar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hold-rating-on-quanterix-akoya-merger-amid-uncertainties-and-potential-synergies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hold-rating-on-quanterix-akoya-merger-amid-uncertainties-and-potential-synergies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","AKYA","BK4539"],"gpt_icon":0},{"id":"2517499171","title":"Akoya Biosciences downgraded to Neutral from Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2517499171","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517499171?lang=en_us&edition=fundamental","pubTime":"2025-03-05 17:55","pubTimestamp":1741168555,"startTime":"0","endTime":"0","summary":"Piper Sandler downgraded Akoya Biosciences (AKYA) to Neutral from Overweight with a price target of $2.40, down from $3, to reflect the pending acq...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/akoya-biosciences-downgraded-to-neutral-from-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/akoya-biosciences-downgraded-to-neutral-from-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKYA"],"gpt_icon":0},{"id":"2517961079","title":"U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International","url":"https://stock-news.laohu8.com/highlight/detail?id=2517961079","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517961079?lang=en_us&edition=fundamental","pubTime":"2025-03-05 15:53","pubTimestamp":1741161195,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott InternationalMarch 5 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO0SE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240877869.USD","LU0965509010.AUD","LU2092937221.SGD","H","AZO","LU0965508806.USD","LU1934455194.USD","ACCD","LU2463526074.USD","INGM","IE00B894F039.SGD","BK4539","BK4114","LU2237443978.SGD","TGT","BOX","CRWD","ACHC","YUM","BBY","LU2106854487.HKD","RSG","BK4139","WDC","AKYA","LU1720051017.SGD","LU2125910336.SGD","LU2238339852.HKD","SNDK","CHPT","LU2360108059.USD","LU2362541513.USD","PASG","SGRY","BK4560","WH","LU2229751404.USD","MGA","LU0240878834.USD","HLT","CHH","MAR","BK4185","LU0211328371.USD","LU0106261612.USD","LU1934455863.HKD","ROST","SION","BK4121","WM"],"gpt_icon":1},{"id":"2517956873","title":"Akoya Biosciences Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $2.4 From $3","url":"https://stock-news.laohu8.com/highlight/detail?id=2517956873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517956873?lang=en_us&edition=fundamental","pubTime":"2025-03-05 11:43","pubTimestamp":1741146221,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nFWN3PN0QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4121","AKYA"],"gpt_icon":0},{"id":"2516661931","title":"Quanterix Announces Acquisition of Akoya Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2516661931","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516661931?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:54","pubTimestamp":1741038853,"startTime":"0","endTime":"0","summary":"An announcement from Quanterix ( ($QTRX) ) is now available. On March 3, 2025, Quanterix announced its proposed acquisition of Akoya Biosciences, a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quanterix-announces-acquisition-of-akoya-biosciences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quanterix-announces-acquisition-of-akoya-biosciences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4539","AKYA"],"gpt_icon":0},{"id":"2516633405","title":"Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633405","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633405?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"Believes Incumbent Board’s Approval and Ongoing Pursuit of Reckless and Dilutive Proposed Merger with Akoya Biosciences Demonstrates Urgent Need for Refreshment. Nominees Would Bring Deep Healthcare and Financial Experience Necessary to Properly Oversee a Standalone Quanterix, Prevent Further Capital Misallocation and Improve Shareholder Value. Kent Lake Urges Shareholders to Vote Against Merger with Akoya to Protect the Future Value of Their Investment. RINCON, Puerto Rico, March 03, 2025----Kent Lake PR LLC , a holder of 6.9% of the outstanding common stock of Quanterix Corporation  , announced today it has nominated three highly qualified, independent candidates for election to the Company’s Board of Directors  at the 2025 Annual Meeting of Shareholders .Former SVP of Strategic Initiatives at Illumina Inc. , an industry pioneer in the life science tools market . Founder/CEO at Luxtera Inc. (acquired by Cisco (NASDAQ: CSCO) f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kent-lake-nominates-three-highly-130000814.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0306806265.USD","QTRX","QID","PRAH","IE00BFXG1179.USD","LU1066051498.USD","LU1023059063.AUD","LU0310800379.SGD","QLD","NQmain","CSCO","EVH","SQQQ","MNQmain","LU1059921491.USD","PSQ","LU0225771236.USD","LU1691799644.USD","LU0868494708.USD","LU0868494617.USD",".IXIC","TQQQ","LU2286300806.USD","LU0203345920.USD","CMBM","LU0528227936.USD","USAW.SI","USJW.SI","LU2237443549.SGD","AKYA","ICLR","LU0170899867.USD","DOMO","LU0792757196.USD","LU2265009873.SGD","ILMN","LU0114720955.EUR","NVIW.SI","TSYW.SI","SGXZ57979304.SGD","IE00B3PB1722.GBP","LU0882574055.USD","SG9999002232.USD","SG9999001176.USD","LU0289960550.SGD","LU0029864427.USD","LU2506951875.HKD","LU1244550577.SGD"],"gpt_icon":1},{"id":"2516277681","title":"Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2516277681","media":"Business Wire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516277681?lang=en_us&edition=fundamental","pubTime":"2025-03-03 19:00","pubTimestamp":1740999600,"startTime":"0","endTime":"0","summary":"Comments on Director Nominations Received from Kent Lake. BILLERICA, Mass., March 03, 2025----Quanterix Corporation  , a company fueling scientific discovery through ultra-sensitive biomarker detection, today reiterated the strategic and financial benefits of its proposed acquisition of Akoya Biosciences, which will create the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein biomarkers. Quanterix issued the following statement:. Expanded Addressable Market. The addition of Akoya’s cutting-edge spatial biology capabilities will unlock a high-growth $5 billion serviceable addressable market across neurology, immunology and oncology, with an additional $10 billion market opportunity in Alzheimer’s Disease diagnostics. By combining Quanterix’s leading position in ultrasensitive detection of proteins in blood and Akoya’s leading position in biomarker detection in tissue, Quanterix will be uniquely positioned to speed up development of new liquid bio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quanterix-highlights-compelling-benefits-akoya-110000754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","QTRX","BK4539","AKYA"],"gpt_icon":0},{"id":"2514340915","title":"Akoya Biosciences Inc  expected to post a loss of 16 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514340915","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514340915?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:29","pubTimestamp":1740742147,"startTime":"0","endTime":"0","summary":"Akoya Biosciences Inc  expected to post a loss of16cents a share - Earnings Preview Akoya Biosciences Inc AKYA.OQ AKYA.O is expected to show a fall in quarterly revenue when it reports  results on Mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ0ZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKYA"],"gpt_icon":0},{"id":"2512948851","title":"Kent Lake: to Nominate Directors to Quanterix Board in 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2512948851","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512948851?lang=en_us&edition=fundamental","pubTime":"2025-02-19 04:40","pubTimestamp":1739911200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nTUA4TM5PB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4121","QTRX","AKYA"],"gpt_icon":0},{"id":"2512419100","title":"Kent Lake Pr Llc: Believes Merger Agreement With Akoya Biosciences Significantly Undervalues Quanterix","url":"https://stock-news.laohu8.com/highlight/detail?id=2512419100","media":"THOMSON REUTERS","labels":["merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512419100?lang=en_us&edition=fundamental","pubTime":"2025-02-19 04:40","pubTimestamp":1739911200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nTUA4TM5PB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge,event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKYA","QTRX","BK4539","BK4121"],"gpt_icon":0},{"id":"2512194046","title":"Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2512194046","media":"Business Wire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512194046?lang=en_us&edition=fundamental","pubTime":"2025-02-19 04:40","pubTimestamp":1739911200,"startTime":"0","endTime":"0","summary":"RINCON, Puerto Rico, February 18, 2025----Kent Lake PR LLC , a holder of 5.9% of the outstanding common stock of Quanterix Corporation  , today highlighted its opposition to the Company’s proposed merger  with Akoya Biosciences  . Kent Lake has also issued an open letter to all Quanterix shareholders outlining how the Merger significantly undervalues the Company and its intention to take all necessary steps to vote against the deal.The full text of the letter can be viewed here.In its letter, Kent Lake details the following key reasons to vote against the Merger:. A Massive and Unjustifiable Valuation Disparity: The deal assigns Quanterix an enterprise value of only $42 million, while valuing the weaker Akoya business at $168 million despite Quanterix’s superior revenue, growth, and market opportunity.A Bailout for Akoya at Quanterix Shareholders’ Expense: Akoya’s financial struggles would have forced it to seek external financing at a deep discount. Instead, Quanterix’s Board of Direc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kent-lake-issues-letter-quanterix-204000573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","AKYA","QTRX","BK4121"],"gpt_icon":0},{"id":"2509275592","title":"Akoya Biosciences unveils strategic product roadmap","url":"https://stock-news.laohu8.com/highlight/detail?id=2509275592","media":"TipRanks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509275592?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:15","pubTimestamp":1738847737,"startTime":"0","endTime":"0","summary":"Akoya Biosciences  announced its reagent product roadmap, featuring new ultrahigh-plex neurobiology panels for human and mouse applications. Building on the success of the Human IO60 and Mouse FFPE IO panels, which debuted at the Society for Immunotherapy of Cancer Annual Meeting in November 2024, this roadmap represents the next step in the company’s mission to provide cutting-edge tools for advancing research across multiple market including oncology, inflammatory disease and neurobiology. Transforming Spatial Proteomics with IO60: Since its launch, the PhenoCode Discovery IO60 panel has been celebrated by key opinion leaders and contract research organizations for its ability to generate deep insights into immune landscapes and tumor-immune interactions. Ultrahigh-Plex Neurobiology Panels: A Major Step Forward: Expanding on the success of IO60, the company is set to release PhenoCode Human and Mouse FFPE Neurobiology panels at the end of Q1 and Q2 2025 respectively.Leverage the powe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/akoya-biosciences-unveils-strategic-product-131537932.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/akoya-biosciences-unveils-strategic-product-131537932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","AKYA","BK4539"],"gpt_icon":0},{"id":"2509283371","title":"Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels","url":"https://stock-news.laohu8.com/highlight/detail?id=2509283371","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509283371?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:00","pubTimestamp":1738760405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nTUA7DPMLL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","AKYA","BK4539"],"gpt_icon":0},{"id":"2509319285","title":"Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels","url":"https://stock-news.laohu8.com/highlight/detail?id=2509319285","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509319285?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:00","pubTimestamp":1738760400,"startTime":"0","endTime":"0","summary":"Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently launched Human IO60 and Mouse FFPE IO Panels The new offerings solidify leadership in spatial biology a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/05/3021104/0/en/Akoya-Biosciences-Unveils-Strategic-Product-Roadmap-Powered-by-the-New-IO60-and-Upcoming-Neurobiology-Panels.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SITC","BK4080","AKYA","BK4231"],"gpt_icon":0},{"id":"2506594879","title":"Akoya Biosciences selects Argonaut Manufacturing as IVD manufacturing partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2506594879","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506594879?lang=en_us&edition=fundamental","pubTime":"2025-01-28 19:10","pubTimestamp":1738062624,"startTime":"0","endTime":"0","summary":"Akoya Biosciences (AKYA) and Argonaut Manufacturing Services, a contract development and manufacturing organization serving the biopharma and life ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/akoya-biosciences-selects-argonaut-manufacturing-as-ivd-manufacturing-partner?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/akoya-biosciences-selects-argonaut-manufacturing-as-ivd-manufacturing-partner?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKYA","BK4539","BK4121"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":119,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AKYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-17","symbol":"AKYA","fiscalQuarterEnding":"2024/12","expectedEps":-0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2024-11-14","symbol":"AKYA","fiscalQuarterEnding":"2024/09","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-08-05","symbol":"AKYA","fiscalQuarterEnding":"2024/06","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-05-13","symbol":"AKYA","fiscalQuarterEnding":"2024/03","expectedEps":-0.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2024-03-04","symbol":"AKYA","fiscalQuarterEnding":"2023/12","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709528400000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AKYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AKYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":8,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AKYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AKYA","date":"2025-05-02","current":-1.088735,"percent":0.989775,"low":-59.648858,"twenty":-14.437924,"median":-4.63458,"eighty":-2.361229,"high":-0.926774,"avg":-9.168454,"sd":10.168448,"marketCap":60277791},"quantilePoints":[{"date":"2021-04-16","current":-59.648858,"twenty":-52.879866,"median":-42.726379,"eighty":-42.726379,"marketCap":996493828},{"date":"2021-04-23","current":-49.067179,"twenty":-53.632932,"median":-51.490371,"eighty":-45.262699,"marketCap":819716288},{"date":"2021-04-30","current":-49.264765,"twenty":-52.612766,"median":-49.659937,"eighty":-48.606145,"marketCap":823017159},{"date":"2021-05-07","current":-43.35914,"twenty":-51.711562,"median":-49.165972,"eighty":-44.448058,"marketCap":724357794},{"date":"2021-05-14","current":-44.78615,"twenty":-50.252694,"median":-48.298789,"eighty":-42.726379,"marketCap":748197417},{"date":"2021-05-21","current":-35.971563,"twenty":-49.89704,"median":-45.433792,"eighty":-41.945302,"marketCap":814576045},{"date":"2021-05-28","current":-34.119724,"twenty":-49.545776,"median":-44.171438,"eighty":-35.863403,"marketCap":772641151},{"date":"2021-06-04","current":-33.218386,"twenty":-49.352581,"median":-42.726379,"eighty":-34.159055,"marketCap":752230362},{"date":"2021-06-11","current":-32.677584,"twenty":-49.225248,"median":-42.162647,"eighty":-33.418319,"marketCap":739983888},{"date":"2021-06-18","current":-31.464875,"twenty":-49.005708,"median":-39.275697,"eighty":-32.739858,"marketCap":712522099},{"date":"2021-06-25","current":-30.891297,"twenty":-48.667616,"median":-35.88143,"eighty":-32.454708,"marketCap":699533415},{"date":"2021-07-02","current":-30.252166,"twenty":-47.877272,"median":-34.31638,"eighty":-32.012233,"marketCap":685060309},{"date":"2021-07-09","current":-31.677919,"twenty":-46.191205,"median":-33.939457,"eighty":-31.677919,"marketCap":717346467},{"date":"2021-07-16","current":-29.006682,"twenty":-46.081435,"median":-33.537951,"eighty":-31.137116,"marketCap":656856310},{"date":"2021-07-23","current":-26.843472,"twenty":-44.78615,"median":-33.283938,"eighty":-30.579926,"marketCap":607870415},{"date":"2021-07-30","current":-28.416715,"twenty":-44.281208,"median":-33.070895,"eighty":-29.793304,"marketCap":643496520},{"date":"2021-08-06","current":-28.334776,"twenty":-44.171438,"median":-32.677584,"eighty":-28.842802,"marketCap":641640994},{"date":"2021-08-13","current":-24.349742,"twenty":-43.35914,"median":-32.46454,"eighty":-28.449491,"marketCap":575213951},{"date":"2021-08-20","current":-24.916015,"twenty":-42.726379,"median":-32.038454,"eighty":-28.416715,"marketCap":588591020},{"date":"2021-08-27","current":-26.064291,"twenty":-42.726379,"median":-31.776246,"eighty":-28.187284,"marketCap":615716742},{"date":"2021-09-03","current":-24.664338,"twenty":-42.327302,"median":-31.464875,"eighty":-27.302334,"marketCap":582645656},{"date":"2021-09-10","current":-22.477895,"twenty":-42.063854,"median":-31.137116,"eighty":-26.841788,"marketCap":530995307},{"date":"2021-09-17","current":-33.032596,"twenty":-41.927739,"median":-31.014207,"eighty":-26.831905,"marketCap":780329004},{"date":"2021-09-24","current":-24.727257,"twenty":-39.802593,"median":-30.579926,"eighty":-26.831905,"marketCap":584131997},{"date":"2021-10-01","current":-22.08465,"twenty":-36.684831,"median":-30.227584,"eighty":-26.032831,"marketCap":521705676},{"date":"2021-10-08","current":-20.275722,"twenty":-35.984673,"median":-29.793304,"eighty":-25.079605,"marketCap":478973374},{"date":"2021-10-15","current":-19.976855,"twenty":-35.827349,"median":-29.170562,"eighty":-24.34345,"marketCap":471913254},{"date":"2021-10-22","current":-19.756638,"twenty":-35.489758,"median":-28.842802,"eighty":-23.648192,"marketCap":466711061},{"date":"2021-10-29","current":-20.841995,"twenty":-34.535979,"median":-28.517579,"eighty":-22.908892,"marketCap":492350443},{"date":"2021-11-05","current":-20.936374,"twenty":-34.159055,"median":-28.433103,"eighty":-22.399246,"marketCap":494579954},{"date":"2021-11-12","current":-16.034124,"twenty":-33.97551,"median":-28.416715,"eighty":-21.914768,"marketCap":496352358},{"date":"2021-11-19","current":-15.493243,"twenty":-33.847684,"median":-28.269224,"eighty":-20.901768,"marketCap":479608838},{"date":"2021-11-26","current":-14.663892,"twenty":-33.706747,"median":-28.187284,"eighty":-20.823119,"marketCap":453935440},{"date":"2021-12-03","current":-14.916303,"twenty":-33.519925,"median":-28.016463,"eighty":-20.624923,"marketCap":461749083},{"date":"2021-12-10","current":-15.385067,"twenty":-33.398654,"median":-27.302334,"eighty":-20.322911,"marketCap":476260134},{"date":"2021-12-17","current":-14.880244,"twenty":-33.316714,"median":-27.112921,"eighty":-20.033482,"marketCap":460632848},{"date":"2021-12-23","current":-16.635104,"twenty":-33.264272,"median":-26.854991,"eighty":-19.813265,"marketCap":514956270},{"date":"2021-12-31","current":-18.401982,"twenty":-33.228219,"median":-26.835051,"eighty":-17.926007,"marketCap":569651770},{"date":"2022-01-07","current":-15.361028,"twenty":-33.14407,"median":-26.103615,"eighty":-16.562986,"marketCap":475515977},{"date":"2022-01-14","current":-14.916303,"twenty":-32.988919,"median":-25.906993,"eighty":-16.199995,"marketCap":461749083},{"date":"2022-01-21","current":-13.822521,"twenty":-32.877517,"median":-25.419369,"eighty":-16.048548,"marketCap":427889964},{"date":"2022-01-28","current":-12.560465,"twenty":-32.690694,"median":-24.821636,"eighty":-15.849023,"marketCap":388821750},{"date":"2022-02-04","current":-13.774443,"twenty":-32.664474,"median":-24.349742,"eighty":-15.755271,"marketCap":426401651},{"date":"2022-02-11","current":-14.615814,"twenty":-32.585811,"median":-23.862118,"eighty":-15.709596,"marketCap":452447127},{"date":"2022-02-18","current":-13.822521,"twenty":-32.474373,"median":-23.232925,"eighty":-15.550938,"marketCap":427889964},{"date":"2022-02-25","current":-14.13503,"twenty":-32.448153,"median":-23.107087,"eighty":-15.385067,"marketCap":437563998},{"date":"2022-03-04","current":-12.091701,"twenty":-32.324266,"median":-22.619463,"eighty":-15.30093,"marketCap":374310699},{"date":"2022-03-11","current":-11.82727,"twenty":-32.038454,"median":-22.477895,"eighty":-15.156695,"marketCap":366124978},{"date":"2022-03-18","current":-11.163601,"twenty":-32.005678,"median":-22.021731,"eighty":-14.964382,"marketCap":479309202},{"date":"2022-03-25","current":-9.618677,"twenty":-31.858186,"median":-21.738594,"eighty":-14.880244,"marketCap":412977905},{"date":"2022-04-01","current":-9.461566,"twenty":-31.694307,"median":-20.920644,"eighty":-14.4235,"marketCap":406232349},{"date":"2022-04-08","current":-9.17353,"twenty":-31.677919,"median":-20.857725,"eighty":-14.243207,"marketCap":393865497},{"date":"2022-04-14","current":-9.810702,"twenty":-31.507484,"median":-20.794805,"eighty":-14.130222,"marketCap":421222473},{"date":"2022-04-22","current":-8.927956,"twenty":-31.438654,"median":-20.708291,"eighty":-13.822521,"marketCap":383321803},{"date":"2022-04-29","current":-8.236477,"twenty":-31.196113,"median":-20.41729,"eighty":-13.630208,"marketCap":353633154},{"date":"2022-05-06","current":-7.136236,"twenty":-31.137116,"median":-20.315047,"eighty":-13.118174,"marketCap":365746370},{"date":"2022-05-13","current":-7.282921,"twenty":-30.940461,"median":-20.118424,"eighty":-12.702296,"marketCap":373264281},{"date":"2022-05-20","current":-7.29759,"twenty":-30.6422,"median":-19.945396,"eighty":-12.428249,"marketCap":374016072},{"date":"2022-05-27","current":-8.302384,"twenty":-30.579926,"median":-19.756638,"eighty":-12.007564,"marketCap":425513762},{"date":"2022-06-03","current":-8.236375,"twenty":-30.428212,"median":-19.190365,"eighty":-11.579259,"marketCap":422130702},{"date":"2022-06-10","current":-7.414938,"twenty":-30.282127,"median":-17.801004,"eighty":-10.845888,"marketCap":380030401},{"date":"2022-06-17","current":-6.857534,"twenty":-30.222668,"median":-16.635104,"eighty":-9.875292,"marketCap":351462339},{"date":"2022-06-24","current":-8.207038,"twenty":-30.091565,"median":-16.46683,"eighty":-9.784517,"marketCap":420627120},{"date":"2022-07-01","current":-9.681225,"twenty":-29.871966,"median":-16.202399,"eighty":-9.636486,"marketCap":496182126},{"date":"2022-07-08","current":-10.289968,"twenty":-29.753973,"median":-16.124271,"eighty":-9.627582,"marketCap":527381456},{"date":"2022-07-15","current":-9.791239,"twenty":-29.544207,"median":-16.022105,"eighty":-9.627582,"marketCap":501820559},{"date":"2022-07-22","current":-9.959927,"twenty":-29.268889,"median":-15.87787,"eighty":-9.627582,"marketCap":510466156},{"date":"2022-07-29","current":-10.32664,"twenty":-28.987016,"median":-15.817772,"eighty":-9.6632,"marketCap":529260934},{"date":"2022-08-05","current":-10.825369,"twenty":-28.895244,"median":-15.745655,"eighty":-9.666805,"marketCap":554821831},{"date":"2022-08-12","current":-9.385512,"twenty":-28.842802,"median":-15.709596,"eighty":-9.609349,"marketCap":593014213},{"date":"2022-08-19","current":-7.484421,"twenty":-28.787083,"median":-15.637478,"eighty":-9.51436,"marketCap":472895679},{"date":"2022-08-26","current":-8.354006,"twenty":-28.545556,"median":-15.541322,"eighty":-9.454817,"marketCap":527839488},{"date":"2022-09-02","current":-7.244536,"twenty":-28.466659,"median":-15.439155,"eighty":-9.400995,"marketCap":457738766},{"date":"2022-09-09","current":-7.946201,"twenty":-28.449491,"median":-15.373047,"eighty":-9.307372,"marketCap":502072736},{"date":"2022-09-16","current":-7.166573,"twenty":-28.433103,"median":-15.30093,"eighty":-9.17353,"marketCap":452812769},{"date":"2022-09-23","current":-6.542872,"twenty":-28.416715,"median":-15.210783,"eighty":-8.998962,"marketCap":413404796},{"date":"2022-09-30","current":-7.046631,"twenty":-28.416715,"median":-15.156695,"eighty":-8.789481,"marketCap":445234313},{"date":"2022-10-07","current":-7.082613,"twenty":-28.416715,"median":-14.99443,"eighty":-8.544414,"marketCap":447507850},{"date":"2022-10-14","current":-7.004651,"twenty":-28.334776,"median":-14.916303,"eighty":-8.302384,"marketCap":442581853},{"date":"2022-10-21","current":-7.778281,"twenty":-28.269224,"median":-14.772068,"eighty":-8.236375,"marketCap":491462897},{"date":"2022-10-28","current":-8.19808,"twenty":-28.261371,"median":-14.459559,"eighty":-8.07214,"marketCap":517987494},{"date":"2022-11-04","current":-8.288037,"twenty":-28.187284,"median":-14.399461,"eighty":-8.07214,"marketCap":523671337},{"date":"2022-11-11","current":-7.26441,"twenty":-28.140625,"median":-14.243207,"eighty":-7.970189,"marketCap":504433339},{"date":"2022-11-18","current":-6.827124,"twenty":-28.140625,"median":-14.165079,"eighty":-7.876996,"marketCap":474068653},{"date":"2022-11-25","current":-7.018436,"twenty":-27.941966,"median":-14.026854,"eighty":-7.769885,"marketCap":487353203},{"date":"2022-12-02","current":-7.034835,"twenty":-27.813639,"median":-13.822521,"eighty":-7.701517,"marketCap":488491879},{"date":"2022-12-09","current":-6.756065,"twenty":-27.400662,"median":-13.720355,"eighty":-7.636749,"marketCap":469134392},{"date":"2022-12-16","current":-6.67954,"twenty":-27.197452,"median":-13.534051,"eighty":-7.604364,"marketCap":463820572},{"date":"2022-12-23","current":-5.548063,"twenty":-27.158121,"median":-13.185484,"eighty":-7.585173,"marketCap":385251948},{"date":"2022-12-30","current":-5.231031,"twenty":-27.104537,"median":-13.035239,"eighty":-7.531199,"marketCap":363237551},{"date":"2023-01-06","current":-5.427809,"twenty":-26.989204,"median":-12.746768,"eighty":-7.482336,"marketCap":376901660},{"date":"2023-01-13","current":-5.892426,"twenty":-26.857295,"median":-12.680661,"eighty":-7.357205,"marketCap":409164138},{"date":"2023-01-20","current":-5.739376,"twenty":-26.841788,"median":-12.464308,"eighty":-7.302979,"marketCap":398536498},{"date":"2023-01-27","current":-6.018145,"twenty":-26.835051,"median":-12.055643,"eighty":-7.248511,"marketCap":417893985},{"date":"2023-02-03","current":-6.55382,"twenty":-26.831905,"median":-12.007564,"eighty":-7.159906,"marketCap":455090725},{"date":"2023-02-10","current":-6.37344,"twenty":-26.677754,"median":-11.517257,"eighty":-7.13172,"marketCap":442565292},{"date":"2023-02-17","current":-6.930979,"twenty":-26.108334,"median":-11.163601,"eighty":-7.099679,"marketCap":481280266},{"date":"2023-02-24","current":-6.668608,"twenty":-26.09575,"median":-10.913381,"eighty":-7.082613,"marketCap":463061455},{"date":"2023-03-03","current":-6.422635,"twenty":-26.064291,"median":-10.64568,"eighty":-7.018436,"marketCap":445981319},{"date":"2023-03-10","current":-5.281166,"twenty":-25.906993,"median":-10.392648,"eighty":-6.968668,"marketCap":373066871},{"date":"2023-03-17","current":-4.363883,"twenty":-25.686775,"median":-10.330307,"eighty":-6.945545,"marketCap":308269028},{"date":"2023-03-24","current":-4.277039,"twenty":-25.419369,"median":-10.267966,"eighty":-6.894205,"marketCap":302134321},{"date":"2023-03-31","current":-4.439871,"twenty":-25.120502,"median":-10.231294,"eighty":-6.870852,"marketCap":313636897},{"date":"2023-04-06","current":-4.043647,"twenty":-24.956912,"median":-10.168953,"eighty":-6.853638,"marketCap":285647296},{"date":"2023-04-14","current":-3.907955,"twenty":-24.765009,"median":-9.996598,"eighty":-6.824405,"marketCap":276061816},{"date":"2023-04-21","current":-3.886689,"twenty":-24.676922,"median":-9.948926,"eighty":-6.794327,"marketCap":274559613},{"date":"2023-04-28","current":-3.65838,"twenty":-24.412661,"median":-9.906714,"eighty":-6.756065,"marketCap":258431636},{"date":"2023-05-05","current":-3.854074,"twenty":-24.324574,"median":-9.811971,"eighty":-6.723172,"marketCap":272255617},{"date":"2023-05-12","current":-3.280429,"twenty":-24.003686,"median":-9.791239,"eighty":-6.677354,"marketCap":239615663},{"date":"2023-05-19","current":-3.133689,"twenty":-23.874702,"median":-9.724142,"eighty":-6.63896,"marketCap":228897179},{"date":"2023-05-26","current":-3.018016,"twenty":-23.780323,"median":-9.6632,"eighty":-6.596489,"marketCap":220447954},{"date":"2023-05-31","current":-3.028532,"twenty":-23.761447,"median":-9.618677,"eighty":-6.552955,"marketCap":221216065},{"date":"2023-06-16","current":-5.384857,"twenty":-23.544375,"median":-9.611549,"eighty":-6.539602,"marketCap":393331484},{"date":"2023-06-22","current":-4.623883,"twenty":-23.336742,"median":-9.600187,"eighty":-6.515011,"marketCap":337746915},{"date":"2023-06-26","current":-4.488456,"twenty":-23.232925,"median":-9.592492,"eighty":-6.512824,"marketCap":327854746},{"date":"2023-07-07","current":-4.191805,"twenty":-23.170006,"median":-9.549208,"eighty":-6.422635,"marketCap":306186185},{"date":"2023-07-14","current":-4.372375,"twenty":-23.116525,"median":-9.470295,"eighty":-6.392024,"marketCap":319375744},{"date":"2023-07-21","current":-4.504578,"twenty":-23.006417,"median":-9.45313,"eighty":-6.350483,"marketCap":329032385},{"date":"2023-07-28","current":-4.28209,"twenty":-22.69182,"median":-9.413525,"eighty":-6.141289,"marketCap":312780964},{"date":"2023-08-04","current":-4.230498,"twenty":-22.619463,"median":-9.400468,"eighty":-6.008336,"marketCap":309012519},{"date":"2023-08-11","current":-3.903629,"twenty":-22.506209,"median":-9.301464,"eighty":-5.935452,"marketCap":298049880},{"date":"2023-08-18","current":-3.339558,"twenty":-22.477895,"median":-9.219166,"eighty":-5.837765,"marketCap":254981917},{"date":"2023-08-25","current":-3.365197,"twenty":-22.163299,"median":-9.155482,"eighty":-5.760355,"marketCap":256939551},{"date":"2023-09-01","current":-3.333148,"twenty":-22.059482,"median":-8.998962,"eighty":-5.686415,"marketCap":254492508},{"date":"2023-09-08","current":-2.910095,"twenty":-22.015439,"median":-8.927956,"eighty":-5.499961,"marketCap":222191536},{"date":"2023-09-15","current":-2.724207,"twenty":-21.971395,"median":-8.743958,"eighty":-5.265531,"marketCap":207998684},{"date":"2023-09-22","current":-2.807536,"twenty":-21.826681,"median":-8.595346,"eighty":-5.151226,"marketCap":214360997},{"date":"2023-09-29","current":-2.980603,"twenty":-21.257262,"median":-8.422973,"eighty":-4.897156,"marketCap":227575031},{"date":"2023-10-06","current":-2.467811,"twenty":-20.936374,"median":-8.348008,"eighty":-4.743654,"marketCap":188422337},{"date":"2023-10-13","current":-2.22103,"twenty":-20.917498,"median":-8.29521,"eighty":-4.610626,"marketCap":169580104},{"date":"2023-10-20","current":-2.454992,"twenty":-20.895476,"median":-8.24523,"eighty":-4.521116,"marketCap":187443520},{"date":"2023-10-27","current":-2.096037,"twenty":-20.889184,"median":-8.243709,"eighty":-4.501353,"marketCap":160036635},{"date":"2023-11-03","current":-2.358843,"twenty":-20.857725,"median":-8.227674,"eighty":-4.482007,"marketCap":180102390},{"date":"2023-11-10","current":-2.866374,"twenty":-20.841995,"median":-8.19808,"eighty":-4.439871,"marketCap":204647641},{"date":"2023-11-17","current":-3.141326,"twenty":-20.794805,"median":-8.017668,"eighty":-4.429015,"marketCap":224278110},{"date":"2023-11-24","current":-3.079462,"twenty":-20.74447,"median":-7.979185,"eighty":-4.394569,"marketCap":219861255},{"date":"2023-12-01","current":-3.017598,"twenty":-20.719302,"median":-7.940203,"eighty":-4.363002,"marketCap":215444399},{"date":"2023-12-08","current":-3.031345,"twenty":-20.703572,"median":-7.843992,"eighty":-4.307144,"marketCap":216425922},{"date":"2023-12-15","current":-3.306297,"twenty":-20.54942,"median":-7.778281,"eighty":-4.267731,"marketCap":236056392},{"date":"2023-12-22","current":-3.278802,"twenty":-20.436166,"median":-7.726644,"eighty":-4.170188,"marketCap":234093345},{"date":"2023-12-29","current":-3.49189,"twenty":-20.410998,"median":-7.712312,"eighty":-4.092497,"marketCap":249306958},{"date":"2024-01-05","current":-3.010724,"twenty":-20.40156,"median":-7.652341,"eighty":-4.032792,"marketCap":214953637},{"date":"2024-01-12","current":-3.629366,"twenty":-20.354371,"median":-7.640347,"eighty":-3.940521,"marketCap":259122193},{"date":"2024-01-19","current":-3.354414,"twenty":-20.291452,"median":-7.622355,"eighty":-3.90709,"marketCap":239491724},{"date":"2024-01-26","current":-3.430026,"twenty":-20.212803,"median":-7.604364,"eighty":-3.874646,"marketCap":244890103},{"date":"2024-02-02","current":-3.821832,"twenty":-20.134154,"median":-7.598294,"eighty":-3.847626,"marketCap":272863521},{"date":"2024-02-09","current":-4.076163,"twenty":-20.080672,"median":-7.571379,"eighty":-3.847626,"marketCap":291021705},{"date":"2024-02-16","current":-4.000551,"twenty":-19.995731,"median":-7.520404,"eighty":-3.821688,"marketCap":285623326},{"date":"2024-02-23","current":-3.677482,"twenty":-19.939104,"median":-7.484421,"eighty":-3.81865,"marketCap":262557525},{"date":"2024-03-01","current":-3.94556,"twenty":-19.904498,"median":-7.428717,"eighty":-3.80886,"marketCap":281697233},{"date":"2024-03-08","current":-3.693917,"twenty":-19.813265,"median":-7.328496,"eighty":-3.80886,"marketCap":233909879},{"date":"2024-03-15","current":-3.77152,"twenty":-19.454626,"median":-7.311063,"eighty":-3.78228,"marketCap":238823952},{"date":"2024-03-22","current":-3.872404,"twenty":-19.215533,"median":-7.275587,"eighty":-3.793191,"marketCap":245212247},{"date":"2024-03-28","current":-3.670636,"twenty":-18.875012,"median":-7.244536,"eighty":-3.776465,"marketCap":232435657},{"date":"2024-04-05","current":-3.274859,"twenty":-18.238516,"median":-7.169571,"eighty":-3.740863,"marketCap":207373884},{"date":"2024-04-12","current":-3.336941,"twenty":-17.839466,"median":-7.144156,"eighty":-3.698341,"marketCap":211305143},{"date":"2024-04-19","current":-2.987727,"twenty":-17.368298,"median":-7.133413,"eighty":-3.663282,"marketCap":189191814},{"date":"2024-04-26","current":-2.978894,"twenty":-16.858668,"median":-7.106899,"eighty":-3.633457,"marketCap":188632486},{"date":"2024-05-03","current":-3.111462,"twenty":-16.587026,"median":-7.097205,"eighty":-3.581838,"marketCap":197027125},{"date":"2024-05-10","current":-3.493572,"twenty":-16.495677,"median":-7.082613,"eighty":-3.538443,"marketCap":221223439},{"date":"2024-05-17","current":-2.106023,"twenty":-16.442791,"median":-7.040733,"eighty":-3.493466,"marketCap":143220116},{"date":"2024-05-24","current":-1.408857,"twenty":-16.329806,"median":-7.004651,"eighty":-3.487766,"marketCap":95809319},{"date":"2024-05-31","current":-1.532314,"twenty":-16.20961,"median":-6.974665,"eighty":-3.466089,"marketCap":104204981},{"date":"2024-06-07","current":-1.517789,"twenty":-16.180763,"median":-6.955595,"eighty":-3.43415,"marketCap":103217256},{"date":"2024-06-14","current":-1.597673,"twenty":-16.142301,"median":-6.949194,"eighty":-3.416278,"marketCap":108649743},{"date":"2024-06-21","current":-1.619459,"twenty":-16.113454,"median":-6.934831,"eighty":-3.400277,"marketCap":110131330},{"date":"2024-06-28","current":-1.771964,"twenty":-16.091818,"median":-6.92278,"eighty":-3.38671,"marketCap":120502442},{"date":"2024-07-05","current":-1.546838,"twenty":-16.034124,"median":-6.892455,"eighty":-3.381909,"marketCap":105192706},{"date":"2024-07-12","current":-1.633984,"twenty":-16.022105,"median":-6.872714,"eighty":-3.360222,"marketCap":111119055},{"date":"2024-07-15","current":-1.677557,"twenty":-16.022105,"median":-6.871783,"eighty":-3.355576,"marketCap":114082230},{"date":"2024-08-02","current":-1.684819,"twenty":-16.022105,"median":-6.870852,"eighty":-3.353192,"marketCap":114576093},{"date":"2024-08-09","current":-1.714204,"twenty":-15.983642,"median":-6.858727,"eighty":-3.337988,"marketCap":103453927},{"date":"2024-08-16","current":-1.796223,"twenty":-15.887486,"median":-6.836731,"eighty":-3.329411,"marketCap":108403876},{"date":"2024-08-23","current":-1.935656,"twenty":-15.829792,"median":-6.820327,"eighty":-3.282528,"marketCap":116818789},{"date":"2024-08-30","current":-2.16531,"twenty":-15.824984,"median":-6.79886,"eighty":-3.259835,"marketCap":130678645},{"date":"2024-09-06","current":-1.95206,"twenty":-15.812964,"median":-6.794327,"eighty":-3.238934,"marketCap":117808779},{"date":"2024-09-13","current":-2.308844,"twenty":-15.784117,"median":-6.763414,"eighty":-3.2066,"marketCap":139341055},{"date":"2024-09-20","current":-2.386763,"twenty":-15.745655,"median":-6.739667,"eighty":-3.156449,"marketCap":144043507},{"date":"2024-09-27","current":-2.222724,"twenty":-15.743251,"median":-6.723027,"eighty":-3.147701,"marketCap":134143609},{"date":"2024-10-04","current":-2.095594,"twenty":-15.728827,"median":-6.67954,"eighty":-3.133689,"marketCap":126471189},{"date":"2024-10-11","current":-2.370359,"twenty":-15.709596,"median":-6.665875,"eighty":-3.093181,"marketCap":143053517},{"date":"2024-10-18","current":-2.509792,"twenty":-15.702384,"median":-6.619413,"eighty":-3.062964,"marketCap":151468430},{"date":"2024-10-25","current":-2.353955,"twenty":-15.659113,"median":-6.599399,"eighty":-3.043417,"marketCap":142063527},{"date":"2024-10-31","current":-2.394964,"twenty":-15.601419,"median":-6.551658,"eighty":-3.031883,"marketCap":144538502},{"date":"2024-11-08","current":-2.641022,"twenty":-15.5894,"median":-6.537422,"eighty":-3.018016,"marketCap":159388348},{"date":"2024-11-15","current":-2.67619,"twenty":-15.541322,"median":-6.481395,"eighty":-3.010724,"marketCap":155133398},{"date":"2024-11-22","current":-1.812627,"twenty":-15.496723,"median":-6.422635,"eighty":-2.987727,"marketCap":105074378},{"date":"2024-11-29","current":-1.881028,"twenty":-15.493939,"median":-6.417168,"eighty":-2.980261,"marketCap":109039449},{"date":"2024-12-06","current":-1.769877,"twenty":-15.406702,"median":-6.387105,"eighty":-2.975303,"marketCap":102596209},{"date":"2024-12-13","current":-2.077681,"twenty":-15.385067,"median":-6.37344,"eighty":-2.961784,"marketCap":120439027},{"date":"2024-12-20","current":-2.180283,"twenty":-15.365836,"median":-6.228589,"eighty":-2.925489,"marketCap":126386634},{"date":"2024-12-27","current":-2.103332,"twenty":-15.332181,"median":-6.147721,"eighty":-2.863936,"marketCap":121925929},{"date":"2025-01-03","current":-2.077681,"twenty":-15.308142,"median":-6.078272,"eighty":-2.852405,"marketCap":120439027},{"date":"2025-01-10","current":-2.274334,"twenty":-15.286506,"median":-6.015412,"eighty":-2.834458,"marketCap":131838606},{"date":"2025-01-17","current":-2.359836,"twenty":-15.226408,"median":-5.952552,"eighty":-2.781897,"marketCap":136794945},{"date":"2025-01-24","current":-2.762213,"twenty":-15.216793,"median":-5.94162,"eighty":-2.762213,"marketCap":160119969},{"date":"2025-01-31","current":-2.556971,"twenty":-15.204773,"median":-5.873295,"eighty":-2.717798,"marketCap":148222510},{"date":"2025-02-07","current":-2.146488,"twenty":-15.156695,"median":-5.815901,"eighty":-2.641022,"marketCap":124427592},{"date":"2025-02-14","current":-1.924142,"twenty":-15.156695,"median":-5.773668,"eighty":-2.625385,"marketCap":111538678},{"date":"2025-02-21","current":-1.761659,"twenty":-15.060538,"median":-5.742109,"eighty":-2.620603,"marketCap":102119856},{"date":"2025-02-28","current":-1.411038,"twenty":-15.026883,"median":-5.693673,"eighty":-2.581585,"marketCap":81795030},{"date":"2025-03-07","current":-1.334072,"twenty":-14.976401,"median":-5.553529,"eighty":-2.566869,"marketCap":77333483},{"date":"2025-03-14","current":-1.265658,"twenty":-14.925919,"median":-5.384857,"eighty":-2.537535,"marketCap":73367664},{"date":"2025-03-21","current":-1.511632,"twenty":-14.916303,"median":-5.264336,"eighty":-2.504123,"marketCap":83691479},{"date":"2025-03-28","current":-1.340673,"twenty":-14.887456,"median":-5.225565,"eighty":-2.479349,"marketCap":74226371},{"date":"2025-04-04","current":-1.097732,"twenty":-14.880244,"median":-5.02332,"eighty":-2.459462,"marketCap":60775955},{"date":"2025-04-11","current":-1.016752,"twenty":-14.707162,"median":-4.903067,"eighty":-2.4258,"marketCap":56292483},{"date":"2025-04-17","current":-0.989759,"twenty":-14.635045,"median":-4.798004,"eighty":-2.404806,"marketCap":54797992},{"date":"2025-04-25","current":-1.142721,"twenty":-14.522061,"median":-4.736515,"eighty":-2.371141,"marketCap":63266773},{"date":"2025-05-02","current":-1.088735,"twenty":-14.437924,"median":-4.63458,"eighty":-2.361229,"marketCap":60277791}],"updateTime":1746426528595}}}